Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
19/08/2026 07:34
BRIEF-Enorama Pharma Q2 Operating Loss SEK 11.7 Mln Aug 19 (Reuters) - Enorama Pharma AB ERMA.ST:
Q2 NET SALES AMOUNTED TO 0 (733) THOUSAND SEK
Q2 OPERATING PROFIT AMOUNTED TO -11,707 (-15,321) THOUSAND SEK
Source text: ID:nWkr8QwQx4
Further company coverage: ERMA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO